Taysha Gene Therapies: Rett Syndrome Information Makes This A Should Watch (NASDAQ:TSHA)

Test tubes in clinic, pharmacy and medical research laboratory and new chemical substances

nuttapong punna/iStock through Getty Photographs

Taysha Gene Therapies (NASDAQ:TSHA) has made nice progress just lately in advancing its gene remedy referred to as TSHA-102 for the remedy of sufferers with Rett Syndrome. Regardless of solely having information from one affected person so

Leave a Reply

Your email address will not be published. Required fields are marked *